Cannabis Related Content

Investment Manager at the Ministry of Foreign Affairs of Denmark, Michael Prytz, charts the rapid development of the medical cannabis market in Europe and provides a look at the Danish model in this vein.

Here, we have a brief look at the different methods of using CBD, and how each method affects bioavailability.

John Binns, Partner at BCL Solicitors LLP looks at the UK’s cannabis laws and how they could be improved.

Laura Clews, Managing Associate at IP attorneys Mathys & Squire, analyses the protection for innovative new products in the medical cannabis & CBD sector.

Dr Nikos Xynos, PhD in Pharmaceutical Sciences/Natural Products Chemistry and MD a Nomad Labs, explores the various pathways to cannabinoid extraction, refining and purification technologies.

Spectrum Therapeutics UK lifts the lid here on a pilot analysis of medicinal cannabis use that will run in Denmark until January 2022.

Following the first two articles that discussed the treatment of cancer and pain, this third piece will focus on the use of cannabinoids to treat psoriasis and rheumatoid arthritis.

Dr. Frank D'Ambrosio, CMO of Block Commodities Plc, provides an insight into the UK’s medical cannabis industry.

Katharina Zedlacher, PR and communications at BioBloom GmbH, details the recent studies conducted to highlight how cannabinoid CBDa (cannabidiolic acid) increases bioavailability of CBD and its health-promoting properties.

David Shurtleff, PhD, Deputy Director at the National Center for Complementary and Integrative Health, National Institutes of Health (NIH), shares his thoughts on closing gaps in cannabinoid research to make progress in pain management.

Gregory Land, CEO at Canna CBD Limited, highlights the dangers of purchasing cannabidiol (CBD) from an unreputable source.

John Wallace, Managing Director at Mile High Labs International, Ltd. explores the market of CBD in food and beverages, including regulation.

In the view of Amanda Feilding, Founder of the Beckley Foundation, “Psychedelics are unique pharmacological compounds that hold the promise of a profound paradigm shift in psychiatry.” Here, we learn about the Psychedelic Renaissance and the importance of drug policy reform.

Here, Christoph Schubert discusses how light is one of the most important factors in the professional cultivation of medical cannabis.

Chris Gunning, General Manager – Accreditation Services at A2LA, discusses the value of accreditation in today’s cannabis industry.

Farrukh Saleem, Head of Sales & Marketing at Winchester MD, explains why the company is ahead of the curve when it comes to today’s market for CBD products.

Jersey Hemp share that they have been granted the first licence in the British Isles to harvest hemp flowers for CBD, in this article.

Here, OilsBySimpson Founder Kevin Simpson and Clinical Professor, Consultant Physician and Research Director, Filip Krag Knop, explain what we know so far about CBD’s effect on Type 2 diabetes and why running a clinical trial is so important.

Content Marketing Specialist, Tammy Taylor details how CBD can be used to treat multiple sclerosis (MS) in this article.

Here, Keeley Berry, Nutritional Expert and Product Developer at BetterYou, answers the most commonly asked questions about CBD.